DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Drospirenone, Ethinyl Estradiol And Levomefolate Calcium patents expire, and when can generic versions of Drospirenone, Ethinyl Estradiol And Levomefolate Calcium launch?
Drospirenone, Ethinyl Estradiol And Levomefolate Calcium is a drug marketed by Lupin Ltd and Watson Labs Inc and is included in three NDAs.
The generic ingredient in DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM is drospirenone; ethinyl estradiol; levomefolate calcium. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
Summary for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM at DailyMed |
Recent Clinical Trials for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bayer | Phase 3 |
See all DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
US Patents and Regulatory Information for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 205947-001 | Jun 13, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs Inc | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 203593-001 | Oct 11, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs Inc | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 203594-001 | Oct 11, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |